Anti-TNF-alpha Biosimilars Humira, Remicade and Enbrel

1st March 2012

Category: Biosimilars

Tags: , , , ,

By: Dr Daniel Galbraith, CSO,

Anti Tumor Necrosis Factor (Anti-TNF) drugs, Humira (adalimumab), Remicade (infliximab) and Enbrel (etanercept) are perhaps the most successful of all biologics both with respect to their turnover and the number of patients treated with these drugs. All have been shown in clinical trials to help with improving the clinical outcome of Rheumatoid Arthritis (RA) but More

Sign-up to our newsletter to be the first to hear about our new services & offers

Sign-up to our newsletter to be the first to hear about our new services & offers

Enter your email address to subscribe to our newsletter which provides information about our services. By subscribing, you are agreeing to the processing of your personal information for this purpose as set out in our privacy policy